Obtained bachelor’s degree from China Medical University in 2006 and master’s degree of Oncology major from China Medical University in 2009. After graduation, worked in Oncology Department of the Fourth Affiliated Hospital of China Medical University, during which he promoted a variety of new anti-tumor drugs into the clinic, has been an other high-level talents in Hainan Province. After years of clinical work, has cultivated good clinical thinking mode and practical operation ability, can make accurate diagnosis of common and frequently occurring malignant tumors, proficiently master the common treatment methods of malignant tumors, and can quickly diagnose and accurately dispose of emergency cases of malignant tumors.

Mainly good at: the treatment of malignant tumors of various parts, such as lung cancer, breast cancer, head and neck, prostate cancer, ovarian cancer, digestive system malignant tumors, etc., the use of systemic treatment including targeted therapy, immunotherapy, chemotherapy, endocrine therapy, combined with radiation therapy, abdominal heat perfusion and other local treatment methods.

Senior Member of Chinese Society of Immunology 
Member of Tumor Thermotherapy Committee of China Anti-Cancer Association 
Standing member of Cancer Health Professional Committee of Hainan Anti-cancer Association 
Member of Tumor Molecular Targeting and Immunity Professional Committee of Hainan Anti-Cancer Association 
Member of the Bone and Soft Tissue Tumor Professional Committee of Hainan Cancer Prevention and Treatment Association
Member of Minimally Invasive Treatment Committee of Hepatobiliary Pancreas, Hainan Anti-Cancer Association
Member of the First Neuroendocrine Tumor Committee of Hainan Anti-Cancer Association

Safe and effective treatment of elderly patients with malignant tumors.

1. Clinical Analysis of Postoperative Chemotherapy-related Anemia in Elderly Patients with Malignant Tumors. Chinese Journal of Cancer, 2015,(37),(04),290-292. First author.

2. Effects of EGFR-TKI Targeted Therapy on Tumor Markers and Survival in Elderly Patients with Advanced Lung Cancer. Chinese Journal of Gerontology, 201,41(03),501-503. First author.

3. Occurrence and Influencing Factors of Myelosuppression after Chemotherapy in Elderly Patients with Colorectal Cancer. Chinese Journal of Gerontology, 201,41(20),4391-4394. First author.

4. Factors of Liver Failure in Patients with Hepatocellular Carcinoma during Targeted Therapy. Journal of Chinese Physician, 202,24(4),622-625. First author.

5. Efficacy of Thymus Pentapeptide Combined with Qingfei Huoturbidity Decoction in the Treatment of Malignant Tumor Complicated with Pulmonary Infection and Its Influence on The Level of PCT, CRP and T Lymphocyte Subsets. Journal of Modern Integrated Chinese and Western Medicine, 2018,(27),(18),1958-1960. First author.

6. Relationship between Hepatitis B Virus Infection and Non-Hodgkin Lymphoma in Some Areas of Fuxin. Chinese Journal of Clinical Research, 2014,(27), (11),1349-1351. First author.

7. Clinical Study of Compound Matrine Injection Combined with Loplatin in the Treatment of Malignant Abdominal Fluid Cccumulation Caused by Gastric Cancer. Liaoning Journal of Traditional Chinese Medicine, 201,48(02),124-125. First author.

8, Erythropoietin Used in Chemotherapy for Advanced Cancer Patients. Guide of China Medicine, 2017,(15),(25),160. First author.